SCHEMBL25682598

SCHEMBL25682598

Cn1c2ccccc2c2ccc3sc4cccc(C(C)(C)C)c4c3c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALKBH5 Q6P6C2 1/20 0.44
▸ FTO Q9C0B1 1/20 0.44
▸ GPR3 P46089 2/20 0.39
▸ HSP90AA1 P07900 1/20 0.37
▸ IDO1 P14902 1/20 0.37
▸ KDM4E B2RXH2 6/20 0.37
▸ MAPT P10636 3/20 0.37
▸ KIF11 P52732 2/20 0.35
▸ ALDH1A1 P00352 4/20 0.33
▸ GABRP O00591 1/20 0.33
▸ GABRD O14764 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRB1 P18505 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA5 P31644 1/20 0.33
▸ GABRA3 P34903 1/20 0.33
▸ GABRA2 P47869 1/20 0.33
▸ GABRB2 P47870 1/20 0.33
▸ GABRA4 P48169 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25682663 0.87 ALKBH5 (0.44) ALKBH5FTOGPR3HSP90AA1IDO1
SCHEMBL25682594 0.87 ALKBH5 (0.44) ALKBH5FTOGPR3HSP90AA1IDO1
SCHEMBL25682550 0.86 GPR3 (0.36) ALKBH5FTOGPR3IDO1KDM4E
SCHEMBL25993503 0.83 GPR3 (0.40) ALKBH5FTOGPR3KDM4EMAPT
SCHEMBL13183686 0.82 ALKBH5 (0.49) ALKBH5FTOGPR3HSP90AA1IDO1
SCHEMBL25993486 0.81 GPR3 (0.39) ALKBH5FTOGPR3MAPTKIF11
SCHEMBL25993409 0.79 ALKBH5 (0.44) ALKBH5FTOGPR3HSP90AA1IDO1
SCHEMBL25993634 0.79 ALKBH5 (0.44) ALKBH5FTOGPR3HSP90AA1IDO1
SCHEMBL20650930 0.78 ALKBH5 (0.59) ALKBH5FTOGPR3HSP90AA1IDO1
SCHEMBL25683902 0.78 ALKBH5 (0.43) ALKBH5FTOGPR3HSP90AA1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
EP-4190791-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT Kyulux, Inc. (JP) 2023-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 ALKBH5 2658/4885FTO 1081/4885GPR3 1535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback